purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of HER2 Target Drugs
1.2 Key Market Segments
1.2.1 HER2 Target Drugs Segment by Type
1.2.2 HER2 Target Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HER2 Target Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global HER2 Target Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global HER2 Target Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HER2 Target Drugs Market Competitive Landscape
3.1 Global HER2 Target Drugs Sales by Manufacturers (2019-2024)
3.2 Global HER2 Target Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 HER2 Target Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global HER2 Target Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers HER2 Target Drugs Sales Sites, Area Served, Product Type
3.6 HER2 Target Drugs Market Competitive Situation and Trends
3.6.1 HER2 Target Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest HER2 Target Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HER2 Target Drugs Industry Chain Analysis
4.1 HER2 Target Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of HER2 Target Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HER2 Target Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global HER2 Target Drugs Sales Market Share by Type (2019-2024)
6.3 Global HER2 Target Drugs Market Size Market Share by Type (2019-2024)
6.4 Global HER2 Target Drugs Price by Type (2019-2024)
7 HER2 Target Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global HER2 Target Drugs Market Sales by Application (2019-2024)
7.3 Global HER2 Target Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global HER2 Target Drugs Sales Growth Rate by Application (2019-2024)
8 HER2 Target Drugs Market Segmentation by Region
8.1 Global HER2 Target Drugs Sales by Region
8.1.1 Global HER2 Target Drugs Sales by Region
8.1.2 Global HER2 Target Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America HER2 Target Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe HER2 Target Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific HER2 Target Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America HER2 Target Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa HER2 Target Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche HER2 Target Drugs Basic Information
9.1.2 Roche HER2 Target Drugs Product Overview
9.1.3 Roche HER2 Target Drugs Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche HER2 Target Drugs SWOT Analysis
9.1.6 Roche Recent Developments
9.2 GSK
9.2.1 GSK HER2 Target Drugs Basic Information
9.2.2 GSK HER2 Target Drugs Product Overview
9.2.3 GSK HER2 Target Drugs Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK HER2 Target Drugs SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Boehringer Digelheim
9.3.1 Boehringer Digelheim HER2 Target Drugs Basic Information
9.3.2 Boehringer Digelheim HER2 Target Drugs Product Overview
9.3.3 Boehringer Digelheim HER2 Target Drugs Product Market Performance
9.3.4 Boehringer Digelheim HER2 Target Drugs SWOT Analysis
9.3.5 Boehringer Digelheim Business Overview
9.3.6 Boehringer Digelheim Recent Developments
9.4 Pfizer
9.4.1 Pfizer HER2 Target Drugs Basic Information
9.4.2 Pfizer HER2 Target Drugs Product Overview
9.4.3 Pfizer HER2 Target Drugs Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca HER2 Target Drugs Basic Information
9.5.2 AstraZeneca HER2 Target Drugs Product Overview
9.5.3 AstraZeneca HER2 Target Drugs Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Seagen
9.6.1 Seagen HER2 Target Drugs Basic Information
9.6.2 Seagen HER2 Target Drugs Product Overview
9.6.3 Seagen HER2 Target Drugs Product Market Performance
9.6.4 Seagen Business Overview
9.6.5 Seagen Recent Developments
9.7 MacroGenics
9.7.1 MacroGenics HER2 Target Drugs Basic Information
9.7.2 MacroGenics HER2 Target Drugs Product Overview
9.7.3 MacroGenics HER2 Target Drugs Product Market Performance
9.7.4 MacroGenics Business Overview
9.7.5 MacroGenics Recent Developments
9.8 Takeda
9.8.1 Takeda HER2 Target Drugs Basic Information
9.8.2 Takeda HER2 Target Drugs Product Overview
9.8.3 Takeda HER2 Target Drugs Product Market Performance
9.8.4 Takeda Business Overview
9.8.5 Takeda Recent Developments
9.9 Daiichi Sankyo
9.9.1 Daiichi Sankyo HER2 Target Drugs Basic Information
9.9.2 Daiichi Sankyo HER2 Target Drugs Product Overview
9.9.3 Daiichi Sankyo HER2 Target Drugs Product Market Performance
9.9.4 Daiichi Sankyo Business Overview
9.9.5 Daiichi Sankyo Recent Developments
9.10 Novartis AG
9.10.1 Novartis AG HER2 Target Drugs Basic Information
9.10.2 Novartis AG HER2 Target Drugs Product Overview
9.10.3 Novartis AG HER2 Target Drugs Product Market Performance
9.10.4 Novartis AG Business Overview
9.10.5 Novartis AG Recent Developments
9.11 RemeGen
9.11.1 RemeGen HER2 Target Drugs Basic Information
9.11.2 RemeGen HER2 Target Drugs Product Overview
9.11.3 RemeGen HER2 Target Drugs Product Market Performance
9.11.4 RemeGen Business Overview
9.11.5 RemeGen Recent Developments
9.12 Sunshine Guojian
9.12.1 Sunshine Guojian HER2 Target Drugs Basic Information
9.12.2 Sunshine Guojian HER2 Target Drugs Product Overview
9.12.3 Sunshine Guojian HER2 Target Drugs Product Market Performance
9.12.4 Sunshine Guojian Business Overview
9.12.5 Sunshine Guojian Recent Developments
9.13 Hengrui Medicine
9.13.1 Hengrui Medicine HER2 Target Drugs Basic Information
9.13.2 Hengrui Medicine HER2 Target Drugs Product Overview
9.13.3 Hengrui Medicine HER2 Target Drugs Product Market Performance
9.13.4 Hengrui Medicine Business Overview
9.13.5 Hengrui Medicine Recent Developments
10 HER2 Target Drugs Market Forecast by Region
10.1 Global HER2 Target Drugs Market Size Forecast
10.2 Global HER2 Target Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe HER2 Target Drugs Market Size Forecast by Country
10.2.3 Asia Pacific HER2 Target Drugs Market Size Forecast by Region
10.2.4 South America HER2 Target Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of HER2 Target Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global HER2 Target Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of HER2 Target Drugs by Type (2025-2030)
11.1.2 Global HER2 Target Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of HER2 Target Drugs by Type (2025-2030)
11.2 Global HER2 Target Drugs Market Forecast by Application (2025-2030)
11.2.1 Global HER2 Target Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global HER2 Target Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings